The Blood Typing Grouping and Infectious Disease Screening market wealth was US$ 3,079.8 Mn in 2017, and will reach US$ 7,078.3 Mn by 2026, with a CAGR of 9.7% during 2018-2026. Based on the Blood Typing Grouping and Infectious Disease Screening industrial chain, this report mainly refines the definition, types, applications and major players of Blood Typing Grouping and Infectious Disease Screening market in details. Wide analysis about market status (2018-2026), advantages and disadvantages of enterprise Products, regional industrial layout characteristics and macroeconomic policies, enterprise competition pattern, industry development trends (2018-2026), industrial policy has also be included. From raw materials to downstream buyers of this industry will be explained accurately, the feature of product circulation and sales channel will be shown as well. In a word, this report will help you to establish a panorama of industrial development and characteristics of the Blood Typing Grouping and Infectious Disease Screening market.
The global blood typing, grouping and infectious disease screening market is projected to reach US$ 7,078.3 Mn by 2026 from US$ 3,079.8 Mn in 2017, growing at a CAGR of 9.7% during the forecast period from 2018 to 2026. The factors contributing to the market growth includes increase in disposable income, rising population, growing awareness regarding blood donations and blood products. According to the Centers for Disease Control and Prevention, the cases of syphilis, a disease caused by Treponema pallidum, has increased by 17.6% in 2016 accounting for 8.7 cases per 100,000 population in the United States. Furthermore, the growing rate of infections catalyze the market growth. According to the HIV.gov (a portal managed by the U.S. Department of Health & Human Services and supported by the Secretary’s Minority AIDS Initiative Fund (SMAIF)), the burden of HIV cases at the end of 2016 was reported around 36.7 million globally among which 2.1 million patients are less than 15 years of age. The global incident cases of HIV in 2016 was reported around 1.8 million that makes around 5,000 infections per day. The global blood typing, grouping and infectious disease screening market is segmented based on the test type, product type, infectious agent, and geography.
Major Players in Heading Indicators market are:
Abbot Laboratories, Inc., Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Inc., DiaSorin S.p.A, F. Hoffmann-La Roche Ltd., Grifols S.A, Immucor, Inc., Ortho Clinical Diagnostics, Quotient Ltd. and Thermo Fisher Scientific, Inc.
Regions play vital role in Heading Indicators market are:
- North America
- United States
- United Kingdom
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- Rest of Middle East & Africa